Expert Interview
A Second Look: Discussing Hoth Therapeutics positive initial data in Phase 2a Clinical Trial CLEER-001, evaluating HT-001 for the treatment of Pruritus associated with skin toxicities caused by EGFR inhibitors
Ticker(s): HOTH
- I am a board-certified dermatologist turned healthcare entrepreneur with a passion for helping people with chronic medical conditions. Each month I treat at least 15 patients for pruritis and at least 2 patients for acneiform rash.
- For people with chronic inflammatory skin conditions, I have developed an app that allows them to take control of their health by implementing scientifically verified lifestyle modifications. I have also created effective, all-natural, steroid-free products that allow them to feel truly comfortable in their own skin.
- I also consult for healthcare organizations. I provide detail-oriented, ethical oversight that assures optimum outcomes for all stakeholders. I am passionate about patient safety and employee training.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
